Regeneron Pharmaceuticals | Des Atouts

Assets Changement Date
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
Amgen USD 97.15B 6.62B 2023-12
AstraZeneca USD 96.09B 457M 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
Ionis Pharmaceuticals USD 2.99B 56.1M 2023-12
Kyowa Hakko Kirin JPY 1T 24.36B 2023-09
Moderna USD 18.43B 1.02B 2023-12
Opthea USD 98.64M 55.37M 2023-06
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Roche Holding CHF 84.37B 3.78B 2023-06
Teva Pharmaceutical Industries USD 42.09B 1.01B 2023-09
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09



Regeneron Pharmaceuticals Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2024.